Donald E. Awrey

1.6k total citations
17 papers, 912 citations indexed

About

Donald E. Awrey is a scholar working on Molecular Biology, Cell Biology and Molecular Medicine. According to data from OpenAlex, Donald E. Awrey has authored 17 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Molecular Medicine. Recurrent topics in Donald E. Awrey's work include Fungal and yeast genetics research (6 papers), RNA and protein synthesis mechanisms (6 papers) and RNA Research and Splicing (5 papers). Donald E. Awrey is often cited by papers focused on Fungal and yeast genetics research (6 papers), RNA and protein synthesis mechanisms (6 papers) and RNA Research and Splicing (5 papers). Donald E. Awrey collaborates with scholars based in Canada, United States and Germany. Donald E. Awrey's co-authors include A.M. Edwards, Caroline M. Kane, C.H. Arrowsmith, Stephen Orlicky, Ken Yamazaki, Guillermo Senisterra, Raymond Hui, Masoud Vedadi, Paul E. Morin and C M Kane and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Cell.

In The Last Decade

Donald E. Awrey

17 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald E. Awrey Canada 16 653 137 110 86 82 17 912
L. Chantalat France 16 805 1.2× 162 1.2× 106 1.0× 110 1.3× 46 0.6× 27 1.2k
Steven Tuske United States 13 655 1.0× 103 0.8× 143 1.3× 152 1.8× 33 0.4× 15 1.1k
Ingo P. Korndörfer Germany 13 916 1.4× 99 0.7× 141 1.3× 50 0.6× 29 0.4× 14 1.3k
A.N. Lebedev Russia 4 677 1.0× 108 0.8× 119 1.1× 48 0.6× 19 0.2× 9 899
Mei-Chu Lo United States 11 750 1.1× 68 0.5× 74 0.7× 117 1.4× 42 0.5× 19 957
Stephen J. Headey Australia 20 579 0.9× 68 0.5× 108 1.0× 61 0.7× 38 0.5× 46 939
D. Ogg United Kingdom 16 673 1.0× 125 0.9× 136 1.2× 150 1.7× 17 0.2× 23 990
Eric Feyfant United States 15 463 0.7× 27 0.2× 61 0.6× 81 0.9× 88 1.1× 22 795
E. Lucile White United States 20 819 1.3× 144 1.1× 242 2.2× 154 1.8× 59 0.7× 38 1.3k
Nancy Su United States 9 576 0.9× 97 0.7× 168 1.5× 219 2.5× 38 0.5× 13 840

Countries citing papers authored by Donald E. Awrey

Since Specialization
Citations

This map shows the geographic impact of Donald E. Awrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald E. Awrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald E. Awrey more than expected).

Fields of papers citing papers by Donald E. Awrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald E. Awrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald E. Awrey. The network helps show where Donald E. Awrey may publish in the future.

Co-authorship network of co-authors of Donald E. Awrey

This figure shows the co-authorship network connecting the top 25 collaborators of Donald E. Awrey. A scholar is included among the top collaborators of Donald E. Awrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald E. Awrey. Donald E. Awrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mason, Jacqueline M., Dan Lin, Wei Xin, et al.. (2014). Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent. Cancer Cell. 26(2). 163–176. 142 indexed citations
2.
Kaplan, Nachum, Donald E. Awrey, Judd Berman, et al.. (2013). In vitroactivity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics. Journal of Chemotherapy. 25(1). 18–25. 29 indexed citations
3.
Nitschké, Felix, Peixiang Wang, Peter Schmieder, et al.. (2013). Hyperphosphorylation of Glucosyl C6 Carbons and Altered Structure of Glycogen in the Neurodegenerative Epilepsy Lafora Disease. Cell Metabolism. 17(5). 756–767. 65 indexed citations
4.
Kaplan, Nachum, Monique Albert, Donald E. Awrey, et al.. (2012). Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor. Antimicrobial Agents and Chemotherapy. 56(11). 5865–5874. 92 indexed citations
5.
Sampson, Peter B., Christine J. Picard, Andrew Leeson, et al.. (2009). Spiro-naphthyridinone piperidines as inhibitors of S. aureus and E. coli enoyl-ACP reductase (FabI). Bioorganic & Medicinal Chemistry Letters. 19(18). 5355–5358. 17 indexed citations
6.
Babu, Mohan, Nevan J. Krogan, Donald E. Awrey, Andrew Emili, & Jack Greenblatt. (2009). Systematic Characterization of the Protein Interaction Network and Protein Complexes in Saccharomyces cerevisiae Using Tandem Affinity Purification and Mass Spectrometry. Methods in molecular biology. 548. 187–207. 22 indexed citations
7.
Ramnauth, Jailall, Peter B. Sampson, Emily Freeman, et al.. (2009). 2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI. Bioorganic & Medicinal Chemistry Letters. 19(18). 5359–5362. 19 indexed citations
8.
Senisterra, Guillermo, et al.. (2006). Screening for Ligands Using a Generic and High-Throughput Light-Scattering-Based Assay. SLAS DISCOVERY. 11(8). 940–948. 103 indexed citations
9.
Awrey, Donald E., et al.. (2003). Intrinsic Transcript Cleavage in Yeast RNA Polymerase II Elongation Complexes. Journal of Biological Chemistry. 278(26). 24189–24199. 30 indexed citations
10.
Harris, Tony, Amir Ravandi, Donald E. Awrey, & Chi‐Hung Siu. (2003). Cytoskeleton Interactions Involved in the Assembly and Function of Glycoprotein-80 Adhesion Complexes in Dictyostelium. Journal of Biological Chemistry. 278(4). 2614–2623. 12 indexed citations
11.
Harris, Tony, Donald E. Awrey, Brian Cox, et al.. (2001). Involvement of a Triton-insoluble Floating Fraction inDictyostelium Cell-Cell Adhesion. Journal of Biological Chemistry. 276(21). 18640–18648. 26 indexed citations
12.
Awrey, Donald E., Christopher M. Koth, Sophia Kazanis, et al.. (1998). Yeast Transcript Elongation Factor (TFIIS), Structure and Function. Journal of Biological Chemistry. 273(35). 22595–22605. 63 indexed citations
13.
Awrey, Donald E., Christopher M. Koth, Xi Shan, et al.. (1998). Yeast Transcript Elongation Factor (TFIIS), Structure and Function. Journal of Biological Chemistry. 273(35). 22589–22594. 55 indexed citations
14.
Awrey, Donald E., et al.. (1997). Transcription Elongation through DNA Arrest Sites. Journal of Biological Chemistry. 272(23). 14747–14754. 101 indexed citations
15.
Morin, Paul E., Donald E. Awrey, A.M. Edwards, & C.H. Arrowsmith. (1996). Elongation factor TFIIS contains three structural domains: solution structure of domain II.. Proceedings of the National Academy of Sciences. 93(20). 10604–10608. 36 indexed citations
16.
Wu, Jing, Donald E. Awrey, A.M. Edwards, Jacques Archambault, & James D. Friesen. (1996). In vitro characterization of mutant yeast RNA polymerase II with reduced binding for elongation factor TFIIS.. Proceedings of the National Academy of Sciences. 93(21). 11552–11557. 46 indexed citations
17.
Christie, Karen, Donald E. Awrey, A.M. Edwards, & C M Kane. (1994). Purified yeast RNA polymerase II reads through intrinsic blocks to elongation in response to the yeast TFIIS analogue, P37.. Journal of Biological Chemistry. 269(2). 936–943. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026